tto neumonía Flashcards
Paciente que no ha recibido tratamiento en los ultimos 3 meses y ni reside en un lugar donde el macrolido no tiene resistencias
Macrolido: Azitromicina 500 mg once daily for 3 days
Intra hospitalario:
2da-3ra generacion de cefalosporinas CEFTRIAZONA, CEFOTAXIME, CEFUROXIME + macrolido (AZITROMICINA O CLARITROMICINA o doxiciclina
UCI
betalactamicos (Ampisulba, cefotaximE)+ Quinolona (Levofloxacina, moxifloxacina)
Riesgo de Pseudomonas intrahospitalario:
Meropenem, Doripenem, Imimpenem, Pipertazo + (Aminoglicosido opcional)
Intrahospitalario con riesgo de SARM
Vancomicina/Linezolid
CURB 65
Confusion, BUN >19.6mg/dl, Respiratoryrate>30breaths/min, systolic BP <90 mg Hg, and diastolic BP ≤60 mm Hg, age ≥65.
***Patients are generally
admitted to the hospital if they fulfill 2 or more criteria and to the ICU if they have 3 or more criteria
LABS
- Hemograma
- Cultivo de sangre
- bun, creatinina
- pulsioximetria
RIESGO DE SARM
- Age 19-29 or >79 years
2.Nursing home, skilled nursing facility, or long term acute care exposure
Within 90 days - Prior IV antibiotic therapy
Within 30 days - Hospitalization for ≥2 days
Within 90 days - ICU admission
On or before index culture
5.Any cerebrovascular disease
Prior to admission
- Dementia
- Female with diabetes mellitu
DOSIS DE LA CEFTRIAXONA
1 g once daily is sufficient for most hemodynamically stable hospitalized patients with CAP (Segev 1995);
for critically ill patients, some experts favor the 2 g dose (File 2019). Total duration (which may include oral step-down therapy) is for a minimum of 5 days and varies based on disease severity and response to therapy; patients should be afebrile for ≥48 hours and clinically
DOSIS DE UCI AMPISULBA +
AMPISULBA: IV: 1.5 to 3 g every 6 hours for ≥5 days (Geckle
moxiflo: Oral, IV: 400 mg every 24 hours
DOSIS DE MEROPENEM
IV: 1 g every 8 hours (ATS/IDSA 2005)
DOSIS DE VANCOMICINA
15 to 20 mg/kg/dose (usual maximum: 2 g/dose initially) every 8 to 12 hours min 7 dias
Dosis de la moxifloxacina
400 mg/24h por 5 diaz